Valuation : bioMérieux

Market Cap 8.74B 10.16B 8.22B 7.51B 14.05B 959B 14.09B 97.16B 37.7B 492B 38.13B 37.3B 1,585B P/E 2026 *
18.2x
P/E 2027 * 16.5x
Enterprise Value 8.33B 9.68B 7.84B 7.16B 13.39B 914B 13.43B 92.62B 35.94B 469B 36.36B 35.56B 1,511B EV / Sales 2026 *
2.02x
EV / Sales 2027 * 1.85x
Free-Float
33.22%
Yield 2026 *
1.41%
Yield 2027 * 1.56%
1 day-2.24%
1 week-1.33%
Current month-1.07%
1 month+3.27%
3 months+1.92%
6 months-22.05%
Current year-32.68%
1 week 74.1
Extreme 74.1
77.9
1 month 72
Extreme 72
77.9
Current year 65.6
Extreme 65.6
116.1
1 year 65.6
Extreme 65.6
118.3
3 years 65.6
Extreme 65.6
128.3
5 years 65.6
Extreme 65.6
133.2
10 years 42.68
Extreme 42.683332
144.8
Manager TitleAgeSince
Chief Executive Officer 53 2023-06-30
Director of Finance/CFO 50 2018-02-28
Chief Tech/Sci/R&D Officer - 2022-07-31
Director TitleAgeSince
Chairman 51 2017-12-14
Director/Board Member 66 2004-12-31
Director/Board Member 61 2012-05-29
Date Insider Type Main position Quantity % Market Cap. Importance
5/6/26 Buy

Chairman

779,245 0.6584%
5/6/26 Buy

Chairman

779,245 0.6584%
5/4/26 Buy

Chairman

404,367 0.3416%
Change 5-day change 1-year change 3-year change Capi.($)
-2.24%-1.33%-37.24%-20.96% 10.16B
+0.23%-0.06%+168.44%+357.12% 21.66B
-0.90%+1.80%+348.78%+19.38% 8.16B
-0.99%-2.18%-28.06% - 7.08B
-0.01%+0.20%+84.42%+52.87% 6.59B
+2.34%-1.27%-20.74%-15.41% 6.03B
-1.82%-1.64%-8.48%-20.67% 4.33B
-0.62%-0.38%+74.99%+85.77% 4.22B
+1.82%-0.27%-18.67%-28.71% 2.81B
+2.23%+6.01% - - 1.39B
Average +0.00%+0.22%+62.60%+53.67% 7.24B
Weighted average by Cap. -0.28%-0.14%+92.58%+127.08%

Financials

2026 *2027 *
Net sales 4.12B 4.79B 3.88B 3.54B 6.63B 453B 6.65B 45.85B 17.79B 232B 18B 17.61B 748B 4.34B 5.04B 4.08B 3.73B 6.97B 476B 6.99B 48.23B 18.71B 244B 18.93B 18.52B 787B
Net income 482M 561M 454M 415M 776M 52.93B 778M 5.36B 2.08B 27.16B 2.11B 2.06B 87.48B 525M 610M 494M 451M 845M 57.64B 847M 5.84B 2.27B 29.57B 2.29B 2.24B 95.26B
Net Debt -408M -474M -384M -350M -655M -44.73B -657M -4.53B -1.76B -22.95B -1.78B -1.74B -73.93B -731M -850M -688M -628M -1.18B -80.23B -1.18B -8.13B -3.15B -41.16B -3.19B -3.12B -133B
Logo bioMérieux
bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.3%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.7%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East /Africa (32.3%), North America (45.4%), Asia/Pacific (15.6%), and Latin America (6.7%).
Employees
14,894
Date Price Change Volume
26-09-04 €74.25 -2.24% 183,032
26-09-03 €75.95 +0.46% 173,721
26-09-02 €75.60 -0.26% 181,455
26-09-01 €75.80 +1.00% 248,593
26-08-31 €75.05 -0.27% 286,298
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
74.25EUR
Average target price
79.04EUR
Spread / Average Target
+6.46%

Quarterly revenue - Rate of surprise